期刊文献+

儿童急性T淋巴细胞性白血病T细胞受体β链基因重排的特点及其在微小残留病定量检测中的意义 被引量:6

Characteristics of T cell receptor beta gene rearrangements and its role in minimal residual disease detection in childhood T-cell acute lymphoblastic leukemia
原文传递
导出
摘要 目的建立以T细胞受体β链(TCRβ)基因重排为分子标志定量检测儿童急性T淋巴细胞性白血病(T—ALL)微小残留病(MRD)的实时定量聚合酶链反应(RQ—PCR)检测体系。方法应用BIOMED-2欧洲协作组设计的PCR检测体系,检测26例初发T—ALL患儿的TCRβ基因重排,并进行序列分析与比对。对其中6例患儿根据基因重排后连接区序列设计等位基因特异性寡核苷酸(ASO)引物,结合胚系TaqMan探针与引物,建立RQ—PCR检测方法,行缓解期标本MRD定量追踪检测。结果92.3%的T—ALL患儿可检测到克隆性TCRβ基因重排[84.6%具有Vβ-(Dβ)-Jβ完全重排,50%具有Dβ-Jβ不完全重排]。通过序列分析,V片段使用频率最高的家族为BV5、BV6,J区使用频率最高的家族为Jβ2.7,J1.3、J2.4、J2.6未被使用。6例患儿ASO标准曲线的斜率为-3.54-3.37,截距为19.35-20.51,相关系数〉0.98。定量范围均达到10^-4。对随访期标本MRD检测发现,复发患儿的MRD水平在复发前显著升高。结论以TCRβ基因重排为分子标志对T—ALL患儿行MRD定量检测,具有较高的敏感度和特异性,动态追踪检测随访期标本MRD水平具有重要的临床价值。 Objective To explore the characteristics of T cell receptor beta (TCRβ) gene rearrangements in children with T-cell acute lymphoblastic leukemia (T-ALL) and establish a system of quantitative detection of MRD with real-time quantitative (RQ-PCR) targeted at TCRβ gene rearrangement. Methods Multiplex polymerase chain reaction (PCR) designed by BIOMED-2 was used to detect TCRβ gene rearrangements in the bone marrow samples of 26 children with T-ALL. Sequence of junction region were then compared and analyzed in IMGT database. Allele specific oligonucleotide (ASO) upstream primers were designed complementary to the V-D-J or D-J junctional region of TCRβ gene rearrangements. Samples at diagnosis were serially diluted in DNA obtained from mononuclear cells (MNC) from a pool of 20 healthy donors to generate the patient specific standard curves. Subsequently, a TCRβ RQ- PCR assay to quantify MRD with germline Jβ primer/probe combinations was applied in six patients. To check the quantity and quality of DNA, the investigators used RQ-PCR analysis for the N-ras gene. Results Clonal rearrangements were identified in 92. 3% childhood T-ALL ( Vβ-Dβ-Jβ rearrangements in 84. 6% , Dβ-Jβ rearrangements in 50% ). Comparative sequence analysis of 42 TCRβ recombinations revealed two downstream Vβ families (BV5, BV6) were preferentially used. The segment Jβ2. 7 in childhood T-ALL was preferentially used. Jβ1. 3, Jβ2.4, and Jβ2. 6 were not found to be used. The slope of the standard curves was from -3.54 to -3.37 and the intercepts were from 19. 35 to 20. 51. The correlation coefficients of all 6 standard curves were excellent ( 1〉 0. 98 ) . All the RQ-PCR quantitative range reached 10^-4. MRD analysis of follow up samples showed that MRD increased before relapse. Conclusion RQ-PCR analysis of TCRβ gene rearrangements was highly sensitive and specific, it will be of high value for future T-ALL MRD studies. And quantitative and serial study of MRD may be of prognostic importance.
出处 《中华儿科杂志》 CAS CSCD 北大核心 2008年第7期487-492,共6页 Chinese Journal of Pediatrics
基金 北京市科技计划资助项目(130905001040431) 北京市科技新星计划资助项目(2005B06)
关键词 基因重排 β链T细胞抗原受体 白血病 T细胞 肿瘤 残余 聚合酶链反应 Gene rearrangement, beta-chain T-cell antigen receptor Leukemia, T-cell Neoplasm, residual Polymerase chain reaction
  • 相关文献

参考文献15

  • 1Hoelzer D, Gokhuget N, Ottmann O, et al. Acute lymphoblastic leukemia. Hematology,2002,1 : 162-192.
  • 2Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med, 2004, 350:1535-1548.
  • 3Coustan- Smith E, Sancho J, Hancock ML, et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood, 2000, 96: 2691-2696.
  • 4WiUemse MJ, Seriu T, Hettinger K, et al. Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL. Blood, 2002, 99 : 4386- 4393.
  • 5van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia, 2003, 17 : 2257-2317.
  • 6Bruggemarm M, van der Velden VHJ, Raft T, et al. Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia. Leukemia, 2004, 18 : 709- 719.
  • 7van der Velden VH, Cazzaniga G, Schrauder A, et al. Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia, 2007, 21 : 604-611.
  • 8Neale GA, Coustan-Smith E, Stow P, et al. Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia, 2004, 18:934-938.
  • 9Sudhakar N, Nancy NK, Rajalekshmy KR, et al. T-cell receptor gamma and delta gene rearrangements and junctional region characteristics in south Indian patients with T-cell acute lymphoblastic leukemia. Am J Hematol,2007, 3:215-221.
  • 10Meleshko AN, Lipay NV, Stasevich IV, et al. Rearrangements of IgH, TCRD and TCRG genes as clonality marker of childhood acute lymphoblastic leukemia. Exp Oncol,2005, 27:319-324.

同被引文献61

  • 1王亚哲,常艳,主鸿鹄,秦亚溱,李金兰,付家瑜,李玲娣,陈珊珊,黄晓军,陆道培,刘艳荣.CD123在急性早幼粒细胞白血病微小残留病检测中的应用[J].中国实验血液学杂志,2006,14(3):427-432. 被引量:13
  • 2崔蕾,李志刚,吴敏媛.急性淋巴细胞白血病微小残留病的定量检测及临床应用[J].国际输血及血液学杂志,2006,29(5):430-433. 被引量:2
  • 3Mullighan CG, Phillips LA, Su XP, et al. Genomie analysis of the clonal origins of relapsed acute lymphoblaslic leukemia [J ]. Science, 2008,322(5906) : 1377 -1380.
  • 4Conter V, Bartram CR, Valsecchi MG, et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B- cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFMALL 2000 study. Blood, 2010, 115 : 3206-3214.
  • 5Flohr T, Schrauder A, Cazzaniga G, et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multieenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastie leukemia. Leukemia, 2008, 22: 771-782.
  • 6Campana D. Minimal residual disease in acute lymphoblastic leukemia. Semi Hematol, 2009, 46: 100-106.
  • 7Cui L, Li ZG, Wu MY, et al. Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B- lineage acute lymphoblastic leukemia. Leuk Res, 2010, 34: 1314-1319.
  • 8Briiggemann M, Schrauder A, Raft T, et al. Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia, 2010, 24:521-535.
  • 9van der Velden VHJ, Cazzaniga G, S(:hrauder A, et al. Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for imerpretation of real-time quantitati~,e PCR data. Leukemia, 2007, 21 : 604-611.
  • 10van tier Velden VHJ, Panzer-Griimayer ER, Cazzaniga G, et al. Optimization of PCR-based minimal residual disease diagnostics for ehihthood acute lymphoblastic leukemia in a multi-center setting. Leukemia, 2007, 21 : 706-713.

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部